Faster global financial news!
Takeda Pharmaceutical Company Limited
TAK NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 30, 2026
ET
EPS Est.
0.17
EPS Actual
0.23
Revenue Est.
$7.13B
Revenue Actual
$7.66B
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q2
EPS Est.
0.14
Revenue Est.
$7.3B
Company Overview
Takeda Pharmaceutical Company Limited (ticker TAK) is listed on NYSE with a market cap of about $57.85B. Its next earnings report (FY2026 Q2) is expected on Oct 29, 2026 (ET), Pre-market, with consensus EPS of 0.14. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Feb 2, 2023 → Jul 30, 2026
Feb 2, 2023Range: -0.22 ~ 0.52Jul 30, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 30, 2026 | -- | 0.17 | Above forecast↑0.23 | $7.13B | $7.66B |
| May 13, 2026 | -- | 0.21 | Below forecast↓-0.05 | $7.14B | $6.92B |
| Jan 29, 2026 | -- | 0.55 | Below forecast↓0.21 | $7.54B | $7.73B |
| Oct 30, 2025 | -- | 0.44 | Below forecast↓-0.02 | $7.79B | $7.22B |
| Jul 30, 2025 | -- | 0.47 | 0.52 | $8.02B | $7.35B |
| May 8, 2025 | -- | 0.24 | Below forecast↓-0.22 | $7.36B | $7.26B |
| Jan 30, 2025 | -- | 0.34 | Below forecast↓0.05 | $7.36B | $7.39B |
| Oct 31, 2024 | -- | 0.39 | Below forecast↓0.19 | $7.45B | $7.69B |
| Jul 31, 2024 | -- | 0.37 | Below forecast↓0.20 | $6.98B | $8.05B |
| May 9, 2024 | -- | 0.00 | Below forecast↓-0.01 | $6.06B | $6.74B |
| Feb 1, 2024 | -- | 0.10 | Above forecast↑0.23 | $6.76B | $7.49B |
| Oct 26, 2023 | -- | 0.10 | Below forecast↓-0.10 | $6.75B | $6.97B |
| Jul 27, 2023 | -- | 0.14 | Above forecast↑0.20 | $7.12B | $7.54B |
| May 11, 2023 | -- | 0.05 | Above forecast↑0.08 | $7.16B | $7.07B |
| Feb 2, 2023 | -- | 0.28 | Above forecast↑0.46 | $7.45B | $8.37B |
Original Filings (SEC)
6-K2026-08-06 ↗
6-K2026-07-30 ↗
6-K2026-07-09 ↗
6-K2026-07-08 ↗
6-K2026-06-29 ↗
6-K2026-06-26 ↗
6-K2026-06-24 ↗
6-K2026-06-24 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
